Landscape of emerging biomarkers in cHL. Established and emerging biomarkers in cHL are grouped according to the context in/from which they can be derived, and their utility in various clinical scenarios is indicated. ECOG, Eastern Cooperative Oncology Group; FDG, fluorodeoxyglucose; IHC, immunohistochemistry.